Abmart - Web3 Crypto Company Profile, Funding, Valuation, Investors - Cointime

Bitcoin $79,523.87 +4.19%
Ethereum $3,194.57 +5.25%
BNB $634.09 +2.60%
Optimism $1.70 +5.77%
Arbitrum $0.64 +6.54%
Solana $206.34 +4.19%
Polygon $0.41 +7.30%
Cosmos $5.31 +13.29%
Avalanche $31.97 +11.18%

Bitcoin $79,523.87 +4.19%
Ethereum $3,194.57 +5.25%
BNB $634.09 +2.60%
Optimism $1.70 +5.77%
Arbitrum $0.64 +6.54%
Solana $206.34 +4.19%
Polygon $0.41 +7.30%
Cosmos $5.31 +13.29%
Avalanche $31.97 +11.18%

Abmart

company

Summary
Funding Rounds
Investors

About

Abmart specializes in antibody customization and antibody-related services.

101 - 250

Highlights

Total Funding Amount

Details

Last Funding Type: Series B
Last Funding Money Raised: ¥20M
Industries: Biotechnology,Medical,Pharmaceutical
Founded date: Jan 22, 2007
Number Of Employee: 101 - 250
Operating Status: Active

Funding Rounds

Number of Funding Rounds

Total Funding Amount

1

¥20M

Abmart has raised a total of ¥20M in funding over 2 rounds. Their latest funding was raised on Jun 12, 2018 from a Series B round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Jun 12, 2018	Series B	¥20M	2	—	—	Detail

Investors

Number of Lead Investors

Number of Investors

—

2

Abmart is funded by 2 investors. Puming Dianli Xitong Gongcheng and Unity Asset Management are the most recent investors.

Investor Name	Lead Investor	Funding Round
Puming Dianli Xitong Gongcheng	—	Series B
Unity Asset Management	—	Series B